Purchase Order 75N95D25P00004
Award Date
10/18/24
Potential Completion Date
1/17/25
Potential Value
$20K
Federal Agency
National Institute on Aging
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance and repair services of Illumina's NovaSeq 6000 sequencing equipment. The contract has a ceiling value of $43,380.00 and a period of performance ending on October 12, 2025. The contract was awarded on a sole-source basis, as Illumina is the original equipment manufacturer of the NovaSeq 6000 sequencer....
This federal contract award is for a firm fixed price delivery order issued by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The $81,793.80 order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $146,953.11 contract does not have a set-aside designation and was awarded on May 21, 2018 with a completion date of May 21, 2019. Illumina has provided a range of sequencing instruments, reagents, and services to...
This is a Firm Fixed Price Delivery Order contract awarded by the National Institute on Aging (NIA), a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a for-profit biotechnology manufacturer. The contract is for the provision of TruSeq and NovaSeq X DNA genome sequencing kits and samples, with a ceiling value of $248,205.26 and a period of performance ending on March 2, 2026. The award did not utilize any set-aside designations, reflecting Illumina's...
This is a delivery order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of reagents and consumables for Illumina's sequencing systems. The contract has a ceiling value of $177,910.34 and is a firm fixed price arrangement with no set-aside designation. Illumina, a manufacturer of genetic and genomic analysis solutions, has previously received other prime federal contracts and...
This is a federal delivery order awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $88,127.98 firm fixed price contract was issued on September 23, 2016 with a period of performance through March 24, 2021. No set-aside designation was used. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to Illumina, Inc. The $213,292.08 award is for the provision of sequencing and array-based solutions to support life science research, applied markets, and molecular diagnostics. Illumina has a history of providing genomic sequencing and analysis products and services, including various sequencing systems, reagents, and...
This is a firm fixed-price delivery order awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is valued at $13,668.73 and does not have a set-aside designation. The award was made on July 26, 2018 with a period of performance through December 31, 2018. Illumina has previously received prime federal contract awards from agencies like the National Institutes...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Illumina, Inc. for a service agreement for a NextSeq 2000 sequencing system. The total ceiling value of the contract is $48,209.00 and it has an ultimate completion date of December 15, 2025. This contract does not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents, and...
This is a federal contract award to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products, by the National Institute on Aging (NIA). The $79,032.05 firm fixed price delivery order does not contain any set-aside provisions. The award supports the NIA's research and diagnostic needs by providing Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans,...